Form 4: Astera Labs President Sanjay Gajendra Sells Shares
Statement of Changes in Beneficial Ownership
Astera Labs President and COO Sanjay Gajendra sold 280,000 shares of common stock via a pre-arranged 10b5-1 trading plan.
Summary
- Sanjay Gajendra, President and COO of Astera Labs, executed the sale of 280,000 shares of common stock on May 19, 2026.
- The transactions were conducted through multiple trusts and a direct holding.
- Sales were executed at weighted average prices ranging from approximately $248.49 to $251.54 per share.
- All transactions were performed automatically pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2025.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event; while insider selling can signal caution, the use of a pre-arranged 10b5-1 plan suggests standard financial planning rather than a reaction to company performance.
Positives
- The sales were pre-planned under a Rule 10b5-1 trading plan, indicating the transactions were not based on sudden non-public information.
Negatives
- Significant insider selling by a top executive (President and COO) may be perceived negatively by some market participants.
Risks
- Continued reliance on Rule 10b5-1 plans for liquidity by key executives could lead to sustained selling pressure on the stock.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Management Comments
- The reporting person disclaims beneficial ownership of the shares held in trusts, except to the extent of his pecuniary interest.
Industry Context
StockSavvy.ai notes that routine insider selling via 10b5-1 plans is a standard practice for executives in the semiconductor and high-growth tech sectors to manage personal liquidity and estate planning.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for corporate officers to avoid potential insider trading allegations.
- The volume of shares sold is consistent with typical executive diversification strategies for high-growth technology companies.
Stakeholder Impact
- Shareholders may observe short-term price volatility following the disclosure of significant insider selling.
Next Steps
- Continued monitoring of future Form 4 filings for further insider activity.
Key Dates
| Date | Description |
|---|---|
| 2025-12-02 | Date the Rule 10b5-1 trading plan was adopted. |
| 2026-05-19 | Date of the earliest transaction reported. |
| 2026-05-21 | Date the Form 4 was signed and filed. |
Keywords
Astera Labs, ALAB, Insider Trading, Form 4, Sanjay Gajendra, Stock Sale, 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.